N/A
Completed N=33
Feasibility of Laryngeal Mask Airway Gastro on Patients Undergoing Endoscopic Retrograde Cholangiopancreatography for Pancreas and Bile Duct Disorders
Bile Duct Disorder · Endocrine Pancreas Disorder
Source: ClinicalTrials.gov NCT03775681 ↗
Enrolled (actual)
33
Serious AEs
0.0%
Results posted
Apr 2021
Primary outcomePrimary: The Number of Participants With Overall Success of ERCP With LMA Gastro — 28 Participants
Summary
This trial determines the feasibility of Laryngeal Mask Airway Gastro (Laryngeal Mask Airway) when used on patients who are undergoing endoscopic retrograde cholangiopancreatography for pancreas and bile duct disorders. Laryngeal Mask Airway is a device that helps patients breathe while they are asleep during procedures.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Number of Participants With Overall Success of ERCP With LMA Gastro |
28 | — |
Eligibility Criteria
Inclusion Criteria
- Adult patients undergoing elective ERCP with general anesthesia
Exclusion Criteria
- Patients with propofol allergy
- Patients at increased aspiration risk
- Patients with abnormal head/neck pathology preventing LMA Gastro placement
- Patients with surgical or radiation treatment to the head/neck making LMA Gastro placement difficult
- Esophagectomy patients
- Patients already intubated upon arrival to endoscopy suite
- Patients undergoing endoscopic ultrasound (EUS)
- Patients with body mass index (BMI) 35 kg/m^2
- Non-English speaking patients
Data sourced from ClinicalTrials.gov (NCT03775681). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.